BioMrieux Financial Statements From 2010 to 2024

BMXMF Stock  USD 108.55  0.00  0.00%   
BioMrieux financial statements provide useful quarterly and yearly information to potential BioMrieux SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioMrieux financial statements helps investors assess BioMrieux's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioMrieux's valuation are summarized below:
BioMrieux SA does not presently have any fundamental signals for analysis.
Check BioMrieux financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioMrieux main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . BioMrieux financial statements analysis is a perfect complement when working with BioMrieux Valuation or Volatility modules.
  
This module can also supplement various BioMrieux Technical models . Check out the analysis of BioMrieux Correlation against competitors.

BioMrieux Net Income Analysis

BioMrieux's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current BioMrieux Net Income

    
  601.1 M  
Most of BioMrieux's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioMrieux SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, BioMrieux SA reported net income of 601.1 M. This is 76.13% higher than that of the Healthcare sector and 247.23% higher than that of the Diagnostics & Research industry. The net income for all United States stocks is 5.28% lower than that of the firm.

BioMrieux SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioMrieux's current stock value. Our valuation model uses many indicators to compare BioMrieux value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioMrieux competition to find correlations between indicators driving BioMrieux's intrinsic value. More Info.
BioMrieux SA is number one stock in beta category among related companies. It is the top company in revenue category among related companies totaling about  21,327,858,497  of Revenue per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioMrieux by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioMrieux's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioMrieux's earnings, one of the primary drivers of an investment's value.

About BioMrieux Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BioMrieux income statement, its balance sheet, and the statement of cash flows. BioMrieux investors use historical funamental indicators, such as BioMrieux's revenue or net income, to determine how well the company is positioned to perform in the future. Although BioMrieux investors may use each financial statement separately, they are all related. The changes in BioMrieux's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioMrieux's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BioMrieux Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BioMrieux. Please read more on our technical analysis and fundamental analysis pages.
bioMrieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is headquartered in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. Biomerieux operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 12084 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioMrieux in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioMrieux's short interest history, or implied volatility extrapolated from BioMrieux options trading.

Pair Trading with BioMrieux

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioMrieux position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMrieux will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to BioMrieux could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioMrieux when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioMrieux - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioMrieux SA to buy it.
The correlation of BioMrieux is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioMrieux moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioMrieux SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioMrieux can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out the analysis of BioMrieux Correlation against competitors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for BioMrieux Pink Sheet analysis

When running BioMrieux's price analysis, check to measure BioMrieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioMrieux is operating at the current time. Most of BioMrieux's value examination focuses on studying past and present price action to predict the probability of BioMrieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioMrieux's price. Additionally, you may evaluate how the addition of BioMrieux to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Please note, there is a significant difference between BioMrieux's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioMrieux is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioMrieux's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.